NCT06847113 Maximal and Self-selected Walkingspeed After Knee Arthroplasty - a Prospective Cohort Study
| NCT ID | NCT06847113 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lovisenberg Diakonale Hospital |
| Condition | Knee Arthroplasty, Total |
| Study Type | OBSERVATIONAL |
| Enrollment | 130 participants |
| Start Date | 2024-11-20 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 130 participants in total. It began in 2024-11-20 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this prospective study is to explore whether maximal and self-selected walking speed in individuals with knee arthroplasty is a useful and applicable clinical measure that can provide new insights into physical function after prosthetic surgery. We will examine the progression of walking speed and other measures of physical function, and investigate if walking speed can predict postoperative function. Individuals over 55 years, scheduled for knee arthroplasty will be invited to participate. Standardized functional tests such as walking speed, sit to stand and one legged stance along with patient reported outcomes will be assessed preoperatively, three months and 12 months after surgery. The study may provide useful knowledge that can be aplied clinically in the assessment and follow-up of this patient group.
Eligibility Criteria
Inclusion Criteria: age 55 +, living in or near the city of Oslo (up to appox 2 hours commute), sceduled for primary knee arthroplasty, able to walk independently with or without walking aids, understand and speak Norwegian sufficently to take instructions and respond to questionnaires Exclusion Criteria: Other reasons than osteoarthritis for knee arthroplasty, revision due to infection or failure, arthroplasty in the same or other limb during the 12 months time period, severe neurological or ohter types of disease that affects walking (e.g MS; parkinsonism, hemiplegiea)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06847113 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Knee Arthroplasty, Total. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06847113 currently recruiting?
Yes, NCT06847113 is actively recruiting participants. Contact the research team at brita.stanghelle@oslomet.no for enrollment information.
Where is the NCT06847113 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT06847113 clinical trial?
NCT06847113 is sponsored by Lovisenberg Diakonale Hospital. The trial plans to enroll 130 participants.